Our lab has pioneered the development of programmable biomaterials using nucleic acids (e.g. aptamers) and hydrogels to mimic the functionality of live cells or tissues that can undergo multiple, dynamic and controllable changes on demand. These biomaterials are currently under rigorous development for drug delivery and regenerative medicine applications. You are welcome to join us to push these novel biomaterials to the next frontier.
Recent News & Events
Jame Coyne’s co-first-author manuscript, Psoriasis-associated impairment of CCL27/CCR10-derived regulation leads to IL-17A/IL-22-producing skin T cell over-activation, has been accepted for publication in The Journal of Allergy and Clinical Immunology (IF: 14.110). This project is in collaboration with Dr. Na Xiong of the UT Health San Antonio.
Dr. Nan Zhao’s first-author manuscript, Exogenous signaling molecules released from aptamer-functionalized hydrogels promote the survival of mesenchymal stem cell spheroids, has been accepted for publication in ACS Applied Materials and Interfaces (IF: 8.456).
Dr. Wang’s special issue article, Special Issue: leaders in Biomedical Engineering, has been accepted for publication in ACS Biomaterials Science & Engineering. (IF: 4.511).